Table 1.
Demographic and clinical characteristics of MMD patients, average scores obtained to the Italian version of Hamilton Rating Scale for Depression (HAM-D; Hamilton, 1980), Beck Depression Inventory-II (BDI-II; Beck et al. 1996) and State-Trait Anxiety Inventory-Y1 (STAI-Y1, State version; Spielberg et al. 1983), and patients’ drug treatment.
| PATIENT | AGE AT ONSET (YEARS) | NUMBER OF DEPRESSIVE EPISODES | PSYCHOTIC SYMPTOMS | HAM-D | BDI-2 | STAI-Y1 | COMORBIDITY SCID-I | ATYPICAL ANTIPSYCHOTIC | ANTIDEPRESSANT | BENZODIAZEPINE | ANTICONVULSANT |
|---|---|---|---|---|---|---|---|---|---|---|---|
| P01 | 23 | 2 | no | 15 | 33 | 53 | Dysthymia | Quetiapine 25 mg | Paroxetine 20 mg | ||
| P02 | 30 | 3 | no | 8 | 9 | 36 | Lifetime Panic Disorder | Citalopram 20 mg | Lamotrigine 100 mg | ||
| P03 | 35 | 2 | no | 0 | 6 | 35 | none | Venlafaxine 150 mg | Lamotrigine 150 mg | ||
| P04 | 58 | 4 | no | 10 | 16 | 34 | none | Paroxetine 20 mg | |||
| P05 | 55 | 2 | no | 6 | 4 | 40 | none | Escitalopram 15 mg | |||
| P06 | 45 | 2 | no | 13 | 12 | 56 | none | Duloxetine 60 mg | Delorazepam 10 gt | ||
| P07 | 40 | 1 | no | 14 | 36 | 48 | none | Duloxetine 30 mg | |||
| P08 | 67 | 2 | no | 4 | 8 | 28 | none | — | |||
| P09 | 35 | 1 | no | 17 | 30 | 68 | none | — | |||
| P10 | 27 | 3 | no | 8 | 4 | 40 | Lifetime Panic Disorder; Social Anxiety Disorder | Venlafaxine 150 mg | Lamotrigine 100 mg | ||
| P11 | 52 | 2 | no | 4 | 2 | 42 | none | Citalopram 20 mg | Flurazepam 30 mg | Valproate 300 mg | |
| P12 | 22 | 1 | no | 9 | 10 | 31 | none | Sertraline 50 mg | |||
| P13 | 32 | 2 | no | 9 | 9 | 37 | Dysthymia | Escitalopram 20 mg | |||
| P14 | 28 | 2 | no | 14 | 23 | 57 | Dysthymia; Lifetime Panic Disorder; Social Anxiety Disorder | — | |||
| P15 | 32 | 5 | no | 13 | 3 | 32 | none | Quetiapine RP 200 mg | Fluoxetine 20 mg | Lamotrigine 100 mg | |
| P16 | 38 | 2 | no | 17 | 24 | 49 | Lifetime Panic Disorder | Sertraline 150 mg | Clonazepam 3 gtt/sera | ||
| P17 | 38 | 2 | no | 11 | 7 | 26 | Lifetime Panic Disorder | Fluoxetine 40 mg | |||
| P18 | 50 | 1 | no | 4 | 10 | 20 | none | Dulaxetine 60 mg Clomipramine 25 mg Trazodone 75 mg | Pregabalin 25 mg | ||
| P19 | 41 | 3 | yes | 0 | 4 | 18 | none | Lorazepam 2.5 mg | |||
| P20 | 49 | 1 | no | 12 | 4 | 19 | none | Sertraline 25 mg | |||
| P21 | 49 | 1 | no | 2 | 14 | 21 | none | Escitalopram 10 mg Mirtazapine 7.5 mg | |||
| P22 | 48 | 4 | no | 11 | 33 | 30 | Dysthymia | Paroxetine 10 mg Fluoxetine 10 mg | Alprazolam 0.50 mg | ||
| P23 | 55 | 10 | no | 12 | 42 | 39 | Dysthymia; Agoraphobia | Perphenazine 2 mg | Escitalopram 20 mg Venlafaxine 150 mg | Alprazolam 1 mg | |
| P24 | 25 | 8 | no | 14 | 1 | 11 | none | Aripiprazole 5 mg | Venlafaxine 150 mg Clomipramine 300 mg | Lorazepam 2.5 mg | Lamotrigine 200 mg |
| P25 | 14 | 5 | yes | 2 | 0 | 20 | Lifetime Panic Disorder | Duloxetine 60 mg Nortriptyline 2.5 mg | Alprazolam 10 gt | ||
| P26 | 37 | 1 | no | 11 | 7 | 12 | none | Venlafaxine 75 mg/150 mg alterned with Mirtazapine 7.5 mg | |||
| P27 | 11.5 | 4 | no | 6 | 15 | 30 | Lifetime Panic Disorder; Agoraphobia | Quetiapine 100 mg | Clonazepam 4 mg | ||
| P28 | 30 | 9 | no | 1 | 3 | 20 | none | Aripiprazole 10 mg | Amitriptyline 25 mg | Clonazepam 2 mg | |
| P29 | 28 | 2 | yes | 8 | 0 | 16 | none | Risperidone 1 mg | Valproate 600 mg | ||
| P30 | 40 | 3 | no | 2 | 1 | 16 | none | Citalopram Chlorhydrate 10 gt |